The Role of Reproductive Surgeons/Surgery has Got Rekindled with Plateauing of IVF Results and Advances in Technology: A Comprehensive Narrative Review

Kulvinder Kochar Kaur^*1, Gautam Nand Allahbadia², Mandeep Singh^3
1Scientific Director, Dr Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India.
²Scientific Director, Ex-Rotunda-A Centre for Human Reproduction, Bandra, Mumbai, India.
³Consultant Neurologist, Swami Satyanand Hospital, Jalandhar, Punjab, India.

Correspondence to: Kulvinder Kochar Kaur, Scientific Director, Dr Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India.
Received date: September 26, 2023; Accepted date: October 23, 2023; Published date: October 30, 2023
Citation: Kaur KK, Allahbadia GN, Singh M. The Role of Reproductive Surgeons/Surgery has Got Rekindled with Plateauing of IVF Results and Advances in Technology: A Comprehensive Narrative Review. J Obst Gynecol Surg. 2023;4(2): 25-36. doi:10.52916/jogs234037
Copyright: ©2023 Kaur KK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

Earlier we have reviewed the role of surgery in need for fibroids removal prior to IVF in improving success rates, management of inoperable recurrent endometrioma presenting as severe incapacitating pain following leuprolide acetate depot by aspiration, recurring again at 2 years subsequently for sclerosing therapy presented as a case report updated advances in classification along with re¬productive surgeries in mullerian anomalies. Updated management of oncofertility-does the use of vsels appear practical in the near future in human malignancies replacing cortical tissue and testicular tissue, autologous Platelet Rich Plasma (PRP) probability of it becoming a revolutionary therapy in the field of gynaecology and reproductive endocrinology and infertility, role of surgery in endometriomas and endometriosis, adenomyomas, tubal surgery. Here we have tried to outline how prior to the invention of In Vitro Fertilization (IVF), reproductive surgeries which were believed to be fertility sparing were properly acknowledged, role of reproductive surgeons became obsolete. With the plateauing of IVF result interest has got rekindled with considerable advantages of reproductive surgeries is this field. Additionally, newer instrumentation as well as along with surgical procedure has evoked and made it attractivefor reproductive surgeons for improvementof their expertise with regards to conservation of future fertility as well as train future Reproductive Endocrinology and Infertility specialist (REI) in view of solidifying this field of yielding pregnancies to maximum of infertile cases even in patients having cancer surgeries or earlier cryopreservation of oocytes in say patients with turners syndrome etc.

Keywords:

Reproductive surgeries, Fertility, Hysteroscopy, Laparoscopic ovarian drilling, Robotic surgery

Funding

No

Refernces

1. Feinberg EC, Levens ED, DeCherney AH. Infertility surgery is dead:only obituaryremains. Fertil Steril. 2008;89(1):232-236.
2. Bortoletto P, Romanski PA, Petrozza JC, et al. Reproductive Surgery:revisiting its origins and role in the modern management of infertility. Fertil Steril. 2023;120(3):539-550.
3. Sutton C. Hysterectomy:a historical perspective. Bailliers Clin Obstet Gynaecol. 1997;11(1):1-22.
4. Speert H. Obstetrics and Gynaecology in America:a history.Chicago. Ill: American College of Obstetricians and Gynaecologists.1980.
5. Chamberlain G.The master of myomectomy. J R Soc Med. 2003;96(6):302-304.
6. Semm K. New methods of pelviscopy (Gynaecologic laparoscopy for myomectomy, ovariectomy, tubectomy and adnectomy. Endoscopy. 1979;11(2):85-93.
7. Advincula AP, Song A, BurkeW, et al. Preliminary experiencewith robotic assisted laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 2004;11(4):511-518.
8. Metwally M, Reybould G, Cheong YC, et al. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2020;2020(1):CD003857.
9. Penzias A, Bendikson K, Butts S, et al. Removal of myomas in asymptomptomatic patients to fertility and/or reduce miscarriage rates. Fertil Steril. 2017;108(3):416-425.
10. Coutinho LM, Assis WA, Spagnuolo-Souza A, et al. Uterine fibroids and pregnancy: how do they affect each other. Reprod Sci. 2022;29(8):2145-2151.
11. Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv. 2009;91(4):1215-1223.
12. Neuwirth RS, Amin HK. Excision of submucus fibroids with hysteroscopiccontrol. Am J Obstet Gynaecol. 1976:126(1):95-99.
13. Barbosa PA, Villaescusa M, Andres MP, et al. How to minimize bleeding in laparoscopic myomectomy. Curr Opin Obstet Gynaecol. 2021;33(4):255-261.
14. Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34(7):74-84.
15. Dolmans MM, Isaacsons K, Zhang W, et al. Intramural myomas more than 3-4 cm in size should be surgically removed before invitro fertilization. Fertil Steril. 2021;116(4):945-958.
16. Kaur KK, Allahbadia GN, Singh M. Need for Removal of Fibroids Prior to IVF in ImprovingSuccess Rates - A Short Commentary. J Gynecol. 2018;3(2):000157.
17. Rackow BW, Taylor HS. Submucosal uterine leiomyomas havea global effect on molecular determinants of endometrial receptivity. Fertil Steril. 2010;93(6):2027-2034.
18. Nezhat C, Nezhat F, Nezhat C. Endometriosis: Ancient disease, Ancient treatments. Fertil Steril. 2012;98(Suppl):S1-62.
19. Junod SW, Marks L. Women’s trial: the approval of the first Oral contraceptives pill in the United States and Great Britain. J Hist Med Allied Sci. 2002;57(2):117-160.
20. Goldberg JM, Falcone T, Diamond MP. Current controversies in tubal disease ,endometriosis and pelvic adhesion. Fertil Steril. 2019;112(3):417-425.
21. Riley KA, Benton AS, Diemling TA, et al. Surgical excision versus ablation for superficial endometriosis-associated pain :a randomized controlled trial. J Minim Invasive Gynaecol. 2019;26(1):71-77.
22. Marcoux S, Maheux R, Berube S. Canadian Collaborative group on minimal endometriosis. N Engl J Med. 1997;337(4):217-222.
23. Practice Committee of the American Society of Reproductive Medicine. Endometriosis and infertility:a Committee opinion. Fertil Steril. 2012;98(3):591-598.
24. Practice Committee of the American Society of Reproductive Medicine. Fertility evaluation ofinfertile women:a Committee opinion. Fertil Steril. 2021;116(5):1255-1265.
25. Kaur KK,Allahbadia GN,Singh M. Current Role of Surgery in Endometriosis; Indications and Progress. Surg Med Open Acc J. 2018;1(4):1-7.
26. Van Pragh I. Conservative surgical treatment for Adenomyosis uteri in young women: local excision and metroplasty. Can Med Assoc J. 1965;93(22):1174-1175.
27. Osada H. Uterine adenomyosis and adenomyoma:the surgical approach. Fertil Steril. 2018;109(3):406-417.
28. Kaur KK, Allahbadia GN, Singh M. Dilemna regarding preference of surgery or medical treatment in case of tubal blockade ,endometriosis or adenomyosis and pelvic adhesion prevention once surgery is contemplated –a systematic review. J Gynaecol Androl Reprod Med. 2020.
29. Hendricks ML, Ket CF, Hampes PGA, et al. Why does ovarian surgery in PCOS help? insight into the endocrine implications of ovarian surgery in Polycystic ovary syndrome. Hum Reprod Update. 2007;13(3):249-264.
30. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral Polycystic ovary syndrome. Am J Obstet Gynaecol. 1935:29(2):181-191.
31. Gjonnaess H. Polycystic ovary syndrometreated byelectrocautery. Fertil Steril. 1984;41(1):20-25.
32. Bordewijk EM, NgKYB, Rakic K, et al. Laparoscopic Ovarian drilling for ovulation inductionin women with anovulatory Polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;2(2):CD001122.
33. Amer SA, Shamy TTE, James C, et al. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve:a meta-analysis. Reprod Camb Engl. 2017;154(1):R13-21.
34. Flyckt R, Goldberg JM. Laparoscopic Ovarian drilling for clomiphene resistant Polycystic ovary syndrome. Semin Reprod Med. 2011;29(2):138-146.
35. Russell WW. Aberrant portion of the mullerian duct found in the ovary. Am J Obstet Gynaecol. 1979:134:225-226.
36. Lee D, Kim SK, Lee JR, et al. Management of Endometriosis-related infertility: considerations and treatment options. Clin Exp Reprod Med. 2020;47(1):1-11.
37. Kitajima M, Dolmans M-M, Donnez O, et al. Enhanced follicular recruitment atresia in cortex derived ovaries with endometriosis. Fertil Steril. 2014;101(4):1031-1037.
38. Zhang Y, Zhang S, Zhao Z, et al. Impact of cystectomy versus ablation for endometrioma on ovarian reserve:a systematic review and meta-analysis. Fertil Steril. 2022;118(6):1172-1182.
39. Muzil L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmfulto healthy ovarian tissue and ovarian reserve than First surgery. Fertil Steril. 2015;103(3):738-743.
40. Muzil L, Achilli C, Bergamini V, et al. Comparison between the stripping technique and the combined excisional /ablative technique for the treatment of bilateral ovarian endometriomas:a multicentre RCT. Hum Reprod. 2016;31(2):339-344.
41. Zhang NN, Sun TS,Yang Q. An effective water injection- assistedmethod for excision of ovarian endometriomas by laparoscopy. Fertil Steril. 2019;112(3):608-609.
42. Candiani GB, Ottolina J, Posadzka E, et al. Asssessment of ovarian reserve after Cystectomy versus’’ one step’’ laser vaporization in the treatment of ovarian endometriomas:a small randomized Clinical trial. Hum Reprod. 2018;33(12):2205-22011.
43. Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117-124.
44. Kaur KK, Allahbadia GN, Singh M. Management of Inoperable Recurrent Endometrioma Presenting as Severe Incapacitating Pain Following Leuprolide Acetate Depot by Aspiration, Recurring Again a 2 Yrs Subsequently for Sclerosing Therapy at Present: A Case Report. Sun Text Rev Case Rep Image. 2020;1(1):107.
45. Surgical treatment of theovaries and fallopian tubes including tubal pregnancy. Bristol Medico Chir. 1896;14(54):353-354.
46. Mulligan WJ. Results of salpingostomy. Int J Fertil.1966;11(4):424-430.
47. Swolin K. Ertilit€atsoperationen. Acta Obstet Gynecol Scand. 1967;46:234–250.
48. https://archive.nytimes.com/www.nytimes.com/interactive/2012/12/30/magazine/the-lives-they-lived-2012.html
49. Gomel V. From laparotomy to laparoscopy to in vitro fertilization. Fertil Steril. 2019;112:183-196.
50. Boeckxstaens A, Devroey P, Collins J, et al. Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod. 2007;22:2660-2664.
51. Society for assisted reproductive technology. American Society of Reproductive Medicine. Assisted reproductive technology in the United States: 2001 results generated from the American Society of Reproductive Medicine/Society for assisted reproductive technology registry. Fertil Steril. 2007;87:1253-1266.
52. Pfeiffer SM, Attaran M, Goldstein I, et al. ASRM Mullerian anomalies classification in 2021. Fertil Steril. 2021;116:1238-1252.
53. Rikken JF, Kowalik CR, Emanuel MH, et al. Septum resection for women of reproductive age with a septate uterus. Cochrane Database Sys Rev. 2017;1:CD008576.
54. Rikken JFW, Kowalik CR, Emanuel MH, et al. The randomized uterine septum transaction trial (TRUST) design and protocol. BMC Womens Health. 2018;18(1):163.
55. Fedele L, Biachi S, Zanconato G, et al. Laparoscopic removal of the cavitated non communicating rudimentary uterine horn: surgical aspects in 10 cases. Fertil Steril. 2005;83:432-436.
56. Fedele L, Dorta M, Brioschi D, et al. Magnetic resonance imaging inMayer-Rokitansky-Kuster-Hauser syndrome. Obstet Gynecol. 1990;76:593-596.
57. Frank RT. Formation of artificial vagina without operation. Am J Obstet Gynecol. 1938;35:1053.
58. Veronikis DK, McClure GB, Nichols DH. The Vecchietti operation for constructing a neovagina: indications, instrumentation, and techniques. Obstet Gynecol. 1997;90:301-304.
59. Wabrek AJ, Millard PR, Wilson WB Jr, et al. Creation of a neovagina by the Frank nonoperative method. Obstet Gynecol. 1971;37:408-413.
60. Costa EM, Mendonca BB, Inacio M, et al. Management of ambiguous genitaliain pseudohermaphrodites: new perspectiveson vaginal dilation. Fertil Steril. 1997;67:229-232.
61. Kaur KK, Allahbadia GN, Singh M. An Update on the Advances in Classification as well as Re¬productive Surgeries in Mullerian Anomalies - A Systematic Review. Am J Surg Tech Case Rep. 2020;1(1):1002.
62. Kaur KK, Allahbadia GN, Singh M. An Update on the Causes of Primaryand Secondary Amenorrhea alongwith Aetiopathogenesis and Therapeutic Management. Avid Science Monograph Series. 2016;1-87.
63. Ingram JM. The bicycle seat stool in the treatment of vaginal agenesis and stenosis: a preliminary report. Am J Obstet Gynecol. 1981;140:867-873.
64. Rall K, Schenk B, Schaffeler N, et al. Long term findings concerning the mental and physical condition, quality of life and sexuality after laparoscopically assisted creation of a neovagina (modified Vecchietti technique) in young MRKHS (Mayer-Rokitansky-Kuster-Hauser syndrome) patients. J Clin Med. 2021;10:1269.
65. Dolinko AV, Vrees RA, Fishman GN. Non tubal ectopic pregnancies: overview and treatment via local injection. J Minim Invasive Gynaecol. 2018;25:287-296.
66. Yamaguchi M, Honda R, Uchino K, et al. Transverse vaginal methotrexate injection for the treatment of caesarean scar pregnancy: efficacy and subsequent fecundity. J Minim Invasive Gynaecol. 2014;21:877-883.
67. Fylstra DL. Ectopic pregnancy within a caesarean scar: a review. Obstet Gynecol Surv. 2002;57: 537-543.
68. Miller R, Timor-Tritsch IE, Gyamfi Bannerman C. Society for Maternal -Fetal Medicine (SFMM) consult series#49 caesarean scar pregnancy. Am J Obstet Gynaecol. 2020:222:82-114.
69. Timor-Tritsch IE, Buca D, Di MascioD, et al. Outcomes of caesarean scar pregnancy according to gestation age at diagnosis: a systematic review and meta-analysis. Eur J Obstet Gynaecol Reprod Biol. 2021;258:53-59.
70. Vissers J, Sluckin TC, van Driel Delprat CCR, et al. Reduced pregnancy and live birth rates after in vitro fertilization in women with a previous caesarean section: a retrospective cohort study. Hum Reprod. 2020;35:595-604.
71. https://pubmed.ncbi.nlm.nih.gov/30196945/
72. Branstrom M, Johanneson L, Bokstrom H, et al. Live birth afteruterus transplantation. Lancet. 2015;385:607-616.
73. Flyckt R, Falcone T, Quintini C, et al. First birth from a deceased donor uterus in the United States: From severe graft rejection to successful caesarean delivery. Am J Obstet Gynecol. 2020: 223:143-151.
74. Ricci S, Bennett C, Falcone T. Uterine transplantation: evolving data, success, and Clinical importance. J Minim Invasive Gynaecol. 2021;28:502-512.
75. Johanneson L, Richards EG, Reddy V, et al. The first 5 years of uterus transplant in the US: a report from the United States uterus transplant Consortium. JAMA Surg. 2022; 157:790-797.
76. McCall ML, Kealy EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma cervix with radical surgery. Am J Obstet Gynecol. 1958;75:590-600.
77. Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril. 1986;45:443-459.
78. Irtan S, Orbach D, Helfre S, et al. Ovarian transpositions in prepubescent and girls with cancer. Lancet Oncol. 2013;14:e601-e608.
79. Gubbala K, Laios A, Gallos I, et al. Outcomes of ovarian transpositions in Gynaecological cancers: A systematic review and meta-analysis. J Ovarian Res. 2014;7:69.
80. McLaren JF, Bates GW. Fertility preservation in women of reproductive age with cancers. Am J Obstet Gynecol. 2012;207:455-467.
81. Seltzer J, Belcht LCG, Huang Y, et al. Utilization of ovarian transpositions for fertility preservation among young women with pelvicmalignancies who undergo radiotherapy. Am J Obstet Gynecol. 2018;219:415-417.
82. Critchley HOD, Bath LE, Wallace WHB. Radiation damage to the uterus- review of the effects of treatment of childhood cancers. Hum Fertil. 2002;5: 61-66.
83. RibeiroR, Ribolho JC, Tsumanuma FK, et al. Uterine transpositions: technique and. case report. Fertil Steril. 2017;108:320-324.
84. Azais H, Canova CH, Vesale E, et al. Laparoscopic uterine fixation to spare fertility before pelvic radiation therapy. Fertil Steril. 2018;110:974-975.
85. Oktay K, Karlikaya G. Ovarianfn after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342:1919.
86. Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377:1657-1665.
87. Stern CJ, Gook D, Hale LG, et al. First reported Clinical pregnancy following heteropic grafting of cryopreserved ovarian tissue in a woman after bilateral oophorectomy. Hum Reprod. 2013;28: 2996-2999.
88. Luo X, Shen Y, Song WX, et al. Pathological evaluation of uterine leiomyoma as treated with radio frequency Ablation. Int J Gynaecol Obstet. 2007;99:9-13.
89. Polin M, Hur HC. Radio frequency Ablation of uterine myomas and pregnancy Outcomes: an updated review of literature. J Minim Invasive Gynaecol. 2022;29:709-715.
90. Lv Q, Wang L, Luo X, et al. Adult stem cells in endometrial regeneration: molecular insights and Clinical applications. Mol Reprod Dev. 2021;88:379-394.
91. Fu YX, Ji J, Shan F, et al. Human mesenchymal stem cells treatment of premature ovarian failure:new challenges and opportunities. Stem Cell Res Ther. 2021;12:161.
92. Gao M, Yu Z, Yao D, et al. Mesenchymal stem cells therapy: a promising method for the treatment of uterine scars premature ovarian failure. Tissue Cell. 2022;74:101674.
93. Kaur KK, Allahbadia GN, Singh M. An Update on Management of Oncofertility-Does the Use of Vsels Appear Practical in the Near Future in Human Malignancies Replacing Cortical Tissue/Testicular Tissue. Int J Stem Cell Regenerat Med. 2019;1(1):103.
94. Kaur KK, Allahbadia GN, Singh M. Autologous Platelet Rich Plasma (PRP): A Possibility of becoming a revolutionary therapy in the field of Gynaecology and reproductive Endocrinology and Infertility- A Systematic Review, Progress in Women's Health Care, 2019;1(1):1-13.
95. Kaur KK, Allahbadia GN, Singh M. Fertility preservation in turners syndrome patients-safety issues and problems of the X chromosomal content of granulosa cells-will it hinder oocytes development still needs Clarification- A short communication. Arch Repr Med Sex Health. 2019;2(2):9-12.
96. Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143:393-408.